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ABSTRACT 
Purpose: We assess the accuracy of endorectal coil magnetic resonance imaging (MRI) for 
detecting tumor localization, capsular penetration and seminal vesicle invasion in clinically 
organ confined prostate cancer. We also evaluate intra-observer and interobserver agreement in 
interpreting MRI studies. 
Materials and Methods: MRI studies of 51 consecutive patients a mean of 61 years old with 
biopsy proved prostate cancer were retrospectively read twice by 2 radiologists in random order. 
Both radiologists marked tumor localization, capsular penetration and seminal vesicle invasion 
on standard tumor maps. These findings were compared with the histopathological results of 
radical prostatectomy specimens. 
Results: The overall accuracy of detecting cancer localization was 61%. The detection rate for 
cancer foci less than 5 mm. was only 5% but for lesions greater than 10 mm. it was 89%. There 
was 91 and 80% accuracy for detecting capsular penetration and seminal vesicle invasion, 
respectively. Sensitivity and specificity were 60 and 63, 13 and 97, and 59 and 84% for localiza- 
tion, capsular penetration and seminal vesicle invasion, respectively. Intra-observer and inter- 
observer agreement ranged from fair to good (kappa coefficient 0.240 to 0.647). 
Conclusions: Endorectal MRI seems to be better than previously reported for detecting seminal 
vesicle invasion and tumor foci in the anterior half of the prostate. Sensitivity in detecting minor 
capsular penetration of the tumor was low, which can probably be improved by methodological 
development. MRI may be useful for locating cancer foci in patients with high prostate specific 
antigen values but repeatedly negative biopsy findings. 
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The incidence of prostatic cancer is increasing. With the 
growing use of prostate specific antigen (PSA) testing more 
early prostate cancer is being detected.' In patients with 
cancer confined to the gland radical prostatectomy is often 
recommended as a potential cure.2 Therefore, accurate can- 
cer staging at  diagnosis is crucial. 
The results of staging clinically localized prostate carci- 
noma with endorectal surface coil magnetic resonance imag- 
ing (MRI) have varied considerably. In 1991 Schnall et a1 
reported 82% accuracy for differentiating stage B from stage 
c ~ a n c e r . ~  In 1992 Krebs and Silverman described similar 
findings4 but after that time various studies have shown 
poorer results. Staging accuracy in the series of Quinn5 and 
Tempany ' et a1 was 51 and 54%, respectively, while Perrotti 
et a1 achieved 64% accuracy for identifying penprostatic soft 
tissue invasion and 77% accuracy for seminal vesicle inva- 
 ion.^ 
TO stage cancer the lesion must first be located. Recently 
Jager et a1 correctly located 67% of tumors.' Presti et a1 
reported 97% sensitivity and 58% specificity for detecting 
tumor laterality.' Tempany' and Schiebler" et a1 have 
shown considerable interobserver variation in interpreting 
MRI. Hricak et a1 obtained fair (kappa = 0.38) agreement 
between consensus and single reader image interpreta- 
tions." The main objective of our study was to determine the 
accuracy of endorectal coil MRI for detecting the localization, 
capsular penetration and seminal vesicle invasion of prostate 
tumors by comparing MRI studies to histopathological find- 
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ings. We also assess intra-observer and interobserver agree- 
ment in interpreting MRI studies by having 2 radiologists 
read them twice in random order. 
MATERIALS AND METHODS 
We retrospectively analyzed the MRI studies of 51 consec- 
utive patients 51 to 74 years old (mean age 61) who under- 
went radical retropubic prostatectomy after imaging. In all 
patients prostate cancer had been histologically proved by 
sextant biopsy, and rectal palpation and transrectal ultra- 
sound had shown organ confined disease. Mean serum PSA 
was 17 pg./l. (range 0 to 100). The interval between biopsy 
and MRI was greater than 3 weeks in all but 2 cases, and the 
mean interval between MRI and prostatectomy was 29 days 
(range 1 to 117). Transurethral resection of the prostate had 
been previously performed in 6 patients and 9 had received 
hormonal therapy, including finasteride in 2 for benign pros- 
tatic hyperplasia and luteinizing hormone-releasing hor- 
mone analogue for prostate cancer in 7. 
MRI was performed using a 1.5 Tesla superconducting 
magnet with a disposable endorectal prostate coil. We ob- 
tained T2-weighted fat suppressed turbo spin echo images in 
the sagittal, axial and coronal directions at  2 acquisitions. 
The time of repetition was 6,000 msec., echo time was 112 
milliseconds and field of view was 150 x 150 mm. Axial and 
sagittal images were acquired in 4 mm. thick sections and 
coronal images were obtained in 3 mm. thick sections with a 
1.2 mm. gap. Of the 51 patients 17 were also imaged with an 
axial 3-dimensional dual echo steady state sequence with 
repetition time 26.8 milliseconds, echo time 9.0 msec., field of 
915 
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view 158 X 180 mm. and slice thickness 2.8 mm. with no gap 
and 1 acquisition. 
MRI studies were retrospectively interpreted twice by 2 of 
us (L. K. and S. I.) in random order. Radiologist experience in 
interpreting prostatic endorectal MRI was limited because 
this technique had only been introduced at our institution 
the previous year. The interval between the 2 readings was 
at  least 1 month. Radiologists were blinded to the clinical 
data, although they knew that all patients had biopsy proved, 
clinically localized prostate cancer. 
Based on MRI findings each radiologist marked tumor 
localization, capsular penetration and seminal vesicle inva- 
sion on standard tumor maps on which the prostate was 
divided into the basis, body and apex (fig. 1). The prostatic 
body was further divided into 8 segments for more specific 
tumor localization, and the capsule was divided into the 
basis, right and leR halves, and apex. The seminal vesicles 
were considered as 1 segment. 
Our criterion for cancer in the peripheral zone was a low 
signal intensity focus. In the central region, consisting of the 
central and transitional zones, a ground glass-like, homoge- 
nous low signal intensity area was the criterion. A localized 
bulge with an irregular margin or direct tumor extension to 
periprostatic soR tissues was defined as capsular penetra- 
tion. The neurovascular bundles were also examined as a 
possible site of extracapsular extension. The criterion for 
seminal vesicle invasion was low signal intensity focus in 
normally bright vesicular tissue. These criteria were derived 
from the literature'*"*'* and our experience. 
Radical retropubic prostatectomy was performed in all pa- 
tients and modified pelvic lymphadenectomy was also done to 
exclude pelvic lymph node metastases. After surgical re- 
moval the intact prostate and seminal vesicles were coated 
over the whole external surface with silver and fixed in 
formalin for 2 to 4 days. After fixation the right prostatic lobe 
was marked with an incision. The seminal vesicles, and api- 
cal and basal urethral margins were removed for histological 
evaluation. The remaining whole prostate was step sectioned 
at  5 mm. intervals. All sections were designated to permit 
localization of each section within the prostate. After paraffin 
embedding all slides were stained according to the Herovici- 
van Gieson method. Sections were examined by a single 
pathologist (P. K J  and cancer areas were outlined with a pen. 
These microscopic findings were then marked on standard 
tumor maps. Tumor maps drawn by the radiologists and the 
pathologist were compared segment by segment in regard to 
cancer localization, capsular penetration and seminal vesicle 
invasion. 
Contingency (2 x 2) tables showed the association between 
MRI and histopathological findings. We calculated binomial 
95% confidence intervals (CI) for accuracy, sensitivity and 
specificity for capsular penetration and seminal vesicle inva- 
sion because the number of positive cases was low. To eval- 
uate intra-observer and interobserver agreement we used 
kappa statistics, and we interpreted kappa values according 
to Altman.13 We performed the chi-square test with the Yaks 
correction for continuity to compare accuracy, sensitivity and 
specificity of MRI diagnoses in the hormone treated and 
nontreated, and transurethral prostatic resection and nonre- 
section groups. Due to multiple comparisons (6) the limit for 
significance was considered at p = 0.01 according to the 
Bonferroni method.14 
RESULTS 
Overall accuracy for detecting tumor localization was 61%, 
sensitivity was 60% and specificity was 63% (table 1). There 
were considerable differences for detecting tumor foci in var- 
ious parts of the prostate (table 2). Localizing cancer foci was 
more difficult in the basis and apex than in the body of the 
prostate with 58,41 and 64% accuracy, respectively. Detect- 
ing tumors in the anterior half of the prostate was less 
accurate than in the posterior half with 61 and 67% accuracy, 
respectively. 
To estimate how well MRI detected small cancer foci we 
counted the lesions less than 5 mm. on the tumor maps of all 
patients. The pathologist had marked 140 lesions and the 
radiologists had marked 7. We also counted lesions greater 
than 10 mm., of which the pathologist had found 62 and the 
radiologists had found 55. 
In 9 patients who had received hormonal treatment before 
MRI there was 56% accuracy for detecting cancer localization 
compared to 62% in those who did not undergo hormonal 
treatment (not statistically significant). There were similar 
findings in the groups that did and did not undergo trans- 
urethral prostatic resection (table 3). 
Pathological evaluation revealed extraprostatic tumor ex- 
tension in 12 of the 51 patients (24%, 14 of 204 possible sites). 
The overall accuracy for discovering penetration was 91% 
(95% CI 87 to 95). Sensitivity was poor at only 13% (95% CI 
2 to 431, whereas specificity reached 97% (94 to 99). There 
were a mean of 2 positive, 184 negative, 5 false-positive and 
12 false-negative cases (table 4). 
Pathological analysis also showed tumor invasion into the 
seminal vesicles in 8 patients (16%). There were a mean of 5 
positive, 36 negative, 7 false-positive and 3 false-negative 
cases. For detecting invasion accuracy was 80% (95% CI 67 to 
901, sensitivity was 59% (24 to 91) and specificity was 84% 
(69 to 93) (table 5). Clinically 17 cases (33%) were under 
staged. When we compared the groups with stages T2 and T3 
disease as interpreted by the radiologists and pathologist, we 
found 69% staging accuracy (table 6). Intra-observer and 
basis 
TABLE 1. Tumor localization 
apex 
I 
' FIG. 1. Division of prostate gland and capsule. Arrows indicate 
capsular penetration. 
~ 
Accuracy Sensitivity Specificity 
i 
Radiologist 1: 
Interpretation 1 3224509 (63) 195/324 (60) 1271185 (69) 
Interpretation 2 30W509 (60) 1824324 (56) 124185 (67) 
Interpretation 1 308/509 (61) 198/324 (61) 110/185 (59) 
Interpretation 2 304/509 (60) 1971324 (61) 107/185 (58) 
Totals 1.240/2.036 (61) 77241.296 (60) 468/740 (63) 
Radiologist 2: 
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TABLE 2 .  Tumor localization in different parts of the prostate 
Prostate Part 
No. CasewTotal No. (%) 
Accuracy Sensitivity Specificity 
TABLE 6.  Stage T2 versus T3 disease 
No. Casedl'otal No. (%) 
Accuracy Sensitivity Specificity 
Body 1,040/1,632 (64) 705/1,040 (68) 335/592 (57) 
Basis 118/204 (58) 20/92 (22) 98/112(88) 
Apex 82/200* (41) 47/164 (29) 35/36 (97) 
Anterior half 495/816 (61) 2W444 (55) 251/372 (67) 
Posterior half 545/816 (67) 461/596 (77) 841220 (38) 
* One apex section was missing. 
Radiologist 1: 
Interpretation 1 33/51 (65) 7/17(41) 26/34 (76) 
Interpretation 2 39/51 (76) 9/17 (53) 30134 (88) 
Interpretation 1 33/51 (65) 9/17 (53) 24/34 (71) 
Interpretation2 36/51 (71) 10/17(59) 26/34 (76) 
Totals 141/204 (69) 35/68 (51) 1W136 (78) 
Radiologist 2 
TABLE 3. The effect of hormonal therapy and transurethral 
prostatic resection on localization of prostate cancer 
No. CasewTotal No. (96) 
Accuracy Sensitivity Specificity 
Hormonal therapy: 
POS. 201/360 (56) 136/244 (56) 65/116(56) 
Neg. 1039/1,676 (62) 636/1,052 (60) 403/624 (65) 
Resection: 
Pos. 140/236 (59) 69/116 (59) 7l/120(59) 
Neg. 1,100/1,800 (61) 703/1,180 (60) 397/620 (64) 
No significant difference between treated and nontreated groups with sig- 
nificance considered at p = 0.01. 
TABLE 4. Capsular Penetration 
No. Casedl'otal No. (96) 
Accuracy* Sensitivity Specificity 
Radiologist 1: 
Interpretation 1 182/203 (90) 1/14 (7) 181/189 (96) 
Interpretation 2 187/203 (92) 2/14 (14) 185/189 (98) 
Radiologist 2: 
Interpretation 1 189/203 (93) 2/14 (14) 1871189 (99) 
Interpretation 2 1W203 (91) 2/14 (14) 182/189 (96) 
Totals 742J812 (91) 7/56 (13) 7351756 (97) 
* One apex section was missing. 
TABLE 5.  Seminal vesicle invasion 
No. CasewTotal No. (%) 
Accuracy Sensitivity Specificity 
~~ 
Radiologist 1: 
Interpretation 1 43/51 (84) 4/8 
Interpretation2 46/51 (90) 6/8 





Interpretation 2 41/51 (80) 5/8 (63) 36/43) 
Totals 164/204 (80) 19/32 (59) 145/172 (84) 
interobserver consistencies were calculated for detecting can- 
cer localization, capsular penetration and seminal vesicle 
invasion, and agreement rates ranged from fair to good (table 
7). 
DISCUSSION 
In all of our patients biopsy proved cancer was confined to 
the prostate based on palpation and transrectal ultrasound. 
Salo et a1 showed that transrectal ultrasound is highly accu- 
rate for revealing local cancer extension beyond the prostatic 
~apsu1e. l~ Thus, our patient population was highly selected 
and our results concern only clinically localized disease. We 
excluded patients with clear extraprostatic growth because 
they did not undergo radical prostatectomy, and SO patholog- 
ical verification was not available. This patient selection 
biased the sensitivity and specificity of capsular penetration 
and seminal vesicle invasion. The knowledge of clinically 
localized disease may also have influenced image interpreta- 
tion. 
Although we were aware of the possibility that changes 
TABLE 7 .  Kappa values of intra-observer and interobserver 
agreement rates 
Ca Capsular Seminal Vesicle 
Localization Penetration Invasion 
Intra-observer: 
F&diolo~st 1 0.576 0.240 0.647 
Radiologist '2 0.462 0.446 0.381 
Interobserver radiologist 1 vs. 2 0.421 0.240 0.463 
Kappa values were interpreted as poor-0.20 or less, fair-0.21 to 0.40, 
rnodeia+0.41 to 0.60, go&-0.61 to-0.80 and very good-0.81 to 1.00. 
after biopsy interfere with image interpretation, there was 
no T1 sequence in our imaging protocol, because the average 
time between biopsy and MRI in our study was greater than 
3 weeks. Recently White et  al reported that, when imaging 
was deferred for 21 days after biopsy, staging accuracy sig- 
nificantly improved.16 In addition, imaging time was already 
prolonged due to axial, sagittal and coronal imaging direc- 
tions and, thus, an even longer imaging time would likely 
have resulted in more motion artifacts. However, by using a 
T1 sequence we may have been able to decrease false-positive 
findings caused by post-biopsy hematoma. 
Another problem with imaging was that fat suppression of 
T2 images may have limited our detection of tumor out- 
growth. However, we had to use this method because of the 
bright signal from fat in turbo spin echo imaging. To resolve 
this problem we added a 3-dimensional dual echo steady 
state sequence to our protocol. We did not separately evalu- 
ate the 17 patients who underwent MRI using both se- 
quences because pathological evaluation revealed capsular 
penetration in only 3. We also believe that using even thinner 
imaging slices (1.5 to 2.0 mm.) would improve the detection of 
capsular penetration and localization of small cancer foci. 
Previous studies have focused on evaluating the staging 
accuracy of MRI in prostatic cancer. In addition to evaluating 
staging accuracy, we assessed the ability of MRI to localize 
cancer foci. Our results suggest that accuracy in detecting 
lesions depends on the location in the prostate. 
Outwater et al identified none of the 29 central gland 
tumors in their study.17 Carter et a1 reported 15% sensitivity 
for tumors located anteriorly versus 85% for those situated 
posteriorly." Our corresponding values were 55 and 77%, 
respectively. The improved identification of anterior tumors 
in our study was probably due to the use of a separate 
criterion (ground glass-like, homogenous low signal intensity 
area) for cancer in the central gland. However, stromal hy- 
perplasia can mimic cancer (figs. 2 and 3), sometimes result- 
ing in false-positive findings. 
To our knowledge no previous studies have described dif- 
ficulty in localizing tumors in the prostatic apex or basis. Our 
results in the apex region were poor, although we also used 
sagittal and coronal imaging directions, in addition to axial 
images, to decrease partial volume effects. More attention 
should be paid to this area, especially since a tumor involving 
the apex can readily invade the extraprostatic tissues?. l9 
Detecting cancer foci in the basis was more difficult than de- 
tecting those in the prostatic body. This finding may be 
important, because cancer usually invades the seminal V ~ S -  
icles by direct tumor spread from the mid base region near 
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FIG. 2. A, axial T2-weighted im e shows carcinoma in anterior part of prostate (arrowheads). B,  same tumor tissue seen on right side, 
normal glands on leR side. Redusfrom X20. 
FIG. 3. A, axial T2-weighted image shows stromal hyperplasia in anterior part of prostate (arrowheads). B,  same stromal hyperplasia 
(upper leR side). Reduced from X40. 
the ejaculatory ductS,2O and seminal vesicle invasion has a 
significantly adverse effect on prognosis.21 
Prostate cancer oRen consists of many small lesions. The 
modest value of sensitivity (60%) in our study may have been 
caused by difficulty in detecting diffuse multifocal types of 
prostatic cancer. On MRI we noted only 5% of tumor foci less 
than 5 mm. in contrast to the histopathological findings. On 
the other hand, such small tumors are not likely to extend to 
the extracapsular tissues. According to Stamey et al, 80% of 
tumors less than 0.5 ml. are unlikely to be significant during 
the life of the patient.22 We detected 89% of the tumor foci 
greater than 10 mm. Other prostatic diseases, such as stro- 
mal hyperplasia or inflammatory foci, may have deleteri- 
ously affected specificity (63%) because they may resemble 
cancer. 
Our results support those of Schiebler" and ChenZ3 et al 
that hormonal therapy may alter MRI findings. However, 
there was no statistically significant difference in cancer 
detection accuracy between the treated and nontreated 
groups. Quinn et al reported that previous transurethral 
pmtatic resection may make tumor delineation difficult but 
we observed no corresponding trend.' 
Compared to previous studiess7 our overall 69% staging 
accuracy seems moderate. Epstein et al showed that estab- 
lished capsular penetration in prostatectomy specimens in- 
dicates a higher risk of progression than in those with focal 
capsular penetration (few neoplastic glands outside the pros- 
tate).= We made no distinction between microscopic and 
macroscopic capsular penetration, because at many sites the 
surgical margins surrounding the specimen were thin and, 
thus, no stages of macroscopic penetration were determined. 
However, extracapsular extension in this material was 
mainly microscopic. This situation as well as the small num- 
ber of extracapsular penetrations were caused by the fact 
that our patients had clinically localized disease, which af- 
fected sensitivity and specificity. The small number of patho- 
logically verified positive cases caused some uncertainty in 
the results. In our series there were poor (13%) sensitivity for 
capsular penetration, 97% specificity and 91% overall accu- 
racy. Perrotti et al reported 22% sensitivity, 84% specificity 
and 64% accuracy with no distinction made between micro- 
scopic and macroscopic penetrati~n.~ In the series of Jager et 
al sensitivity was 14% when penetration was less than 1 
mm., 67% when it was 1 to 3 mm. and 100% when it was 
greater than 3 111111.' 
For detecting seminal vesicle invasion Jager et al' reported 
36% sensitivity but only 9% specificity. The study of Perrotti 
et al also had low sensitivity (23%) but better specificity 
(93%); while Tempany et a1 reported values of 21 and 85%, 
respectively? Our corresponding values were 59 and 84% 
with clearly better sensitivity than in previous studies. Un- 
fortunately 7 false-positive cases were also found. All of our 
patients had undergone transrectal ultrasound before MRI. 
and were supposed to have localized disease based on ultra- 
sound findings. However, MRI revealed seminal vesicle in- 
vasions, and so MRI seems to be more sensitive than trans- 
rectal ultrasound in this respect. 
Our results show no difference from those of previous stud- 
ies in regard to considerable interobserver variation in inter- 
preting MRI? ''* '' For tumor localization intra-observer and 
interobserver agreements were moderately consistent. 
Agreement between readers was weakest in detecting capsu- 
MAGNETIC RESONANCE IMAGING OF CLINICALLY LOCALIZED PROSTATIC CANCER 919 
1 s  penetration and  best in detecting seminal vesicle inva- 
sion. Consensus training in the interpretation of MRI may 
improve results. Generally intra-observer agreement was  
somewhat better than interobserver agreement. Partial im- 
provement on the second reading was  probably caused by our  
pilot series, which was analyzed during the study period. 
When we s tar ted this study in 1995 contrast enhancement 
1 was considered to  be of no particular use in  MRI for prostatic 
cancer. Jager et a1 have now reported better results using the 
gadolinium enhanced dynamic subtracted technique com- 
pared with T2-weighted fast spin echo images.26 Sensitivity, 
specificity and accuracy for detecting tumor involvement on 
enhanced images were 73.5, 81.0 and 77.5% compared with 
57.5, 80.5 and 72.0% on fast spin echo images, respectively. 
The depiction of capsular penetration and tumor staging 
were also better when enhanced images were included. How- 
ever, there was  no statistically significant difference between 
the 2 sequences. There are also new studies of prostatic MFtI 
using pelvic phased ar ray  coils. Husband et al reported that 
pelvic phased ar ray  coil imaging visualizes the anterior gland 
and neurovascular bundles better than endorectal coil imag- 
ing.26 In their study there was no difference in tumor staging. 
Earlier Hricak et al noted better results using integrated 
endorectal pelvic phased array coils than phased array coils 
only. The further development of MRI techniques for imag- 
ing the prostate will probably improve results in the future. 
CONCLUSIONS 
MRI seems to  be more sensitive for detecting seminal ves- 
icle invasion than transrectal ultrasound. Sensitivity for de- 
tecting minor capsular penetration was low but it may be 
improved by dynamic contrast enhancement and new coil 
technology. Identifying cancer foci in the anterior half of the 
prostate was  more reliable than previously reported. The 
detection rate of tumors greater than 10 mm. was  good, and 
SO MRI may be useful for locating cancer foci in patients with 
high PSA values but  repeatedly negative biopsy findings. 
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